NCT05693272View on ClinicalTrials.gov

A Clinical Trial to Study the COVAC-1 Booster Dose in Generally Healthy Adults

PHASE1CompletedINTERVENTIONAL
Enrollment

47

Participants

Timeline

Start Date

January 31, 2023

Primary Completion Date

June 4, 2024

Study Completion Date

June 4, 2024

Conditions
Severe Acute Respiratory Syndrome Coronavirus 2 Infection
Interventions
BIOLOGICAL

COVAC-1

Intramuscular vaccine against SARS-CoV-2

BIOLOGICAL

Saline Placebo

Intramuscular injection of saline placebo

Trial Locations (4)

J6E 2B4

Diex Recherche Joliette Inc., Joliette

G1V 4T3

Diex Recherche Quebec Inc., Québec

J1L 0H8

Diex Recherche Sherbrooke, Sherbrooke

G6P 6P6

DIEX Recherche Victoriaville, Victoriaville

All Listed Sponsors
collaborator

Government of Canada

OTHER_GOV

collaborator

Government of Saskatchewan

OTHER_GOV

lead

University of Saskatchewan

OTHER